首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity
【24h】

Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity

机译:DNA促旋酶B(GyrB)和拓扑异构酶IV(ParE)的吡咯并嘧啶抑制剂。第一部分:结构导向的发现和具有强力,广谱酶活性的双重靶向剂的优化

获取原文
获取原文并翻译 | 示例
           

摘要

The bacterial topoisomerases DNA gyrase (GyrB) and topoisomerase IV (ParE) are essential enzymes that control the topological state of DNA during replication. The high degree of conservation in the ATP-binding pockets of these enzymes make them appealing targets for broad-spectrum inhibitor development. A pyrrolopyrimidine scaffold was identified from a pharmacophore-based fragment screen with optimization potential. Structural characterization of inhibitor complexes conducted using selected GyrB/ParE orthologs aided in the identification of important steric, dynamic and compositional differences in the ATP-binding pockets of the targets, enabling the design of highly potent pyrrolopyrimidine inhibitors with broad enzymatic spectrum and dual targeting activity. ? 2012 Elsevier Ltd. All rights reserved.
机译:细菌拓扑异构酶DNA回旋酶(GyrB)和拓扑异构酶IV(ParE)是在复制过程中控制DNA拓扑状态的必需酶。这些酶在ATP结合袋中的高度保守性使其成为广谱抑制剂开发的诱人靶标。从基于药效基团的片段筛选中鉴定出具有最佳潜力的吡咯并嘧啶骨架。使用选定的GyrB / ParE直系同源物进行的抑制剂复合物的结构表征有助于鉴定靶标ATP结合口袋中的重要空间,动态和组成差异,从而可以设计具有宽酶谱和双重靶向活性的高效吡咯并嘧啶抑制剂。 ? 2012 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号